![Zhen Pan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhen Pan
Directeur/Bestuurslid bij SHANGHAI GUIJIU CO.,LTD
Profiel
Zhen Pan is currently working as a Director at Shanghai Guijiu Co., Ltd.
and as a Member-Supervisory Board at Hebei Yipin Pharmaceutical Co., Ltd.
He holds a Master's degree in Business Administration from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.
Actieve functies van Zhen Pan
Bedrijven | Functie | Begin |
---|---|---|
SHANGHAI GUIJIU CO.,LTD | Directeur/Bestuurslid | 01-09-2021 |
Hebei Yipin Pharmaceutical Co., Ltd.
![]() Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Directeur/Bestuurslid | 01-03-2021 |
Opleiding van Zhen Pan
Shanghai Jiao Tong University | Masters Business Admin |
Shanghai University of Finance & Economics | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHANGHAI GUIJIU CO.,LTD | Consumer Non-Durables |
Bedrijven in privébezit | 1 |
---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
![]() Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |